Clinical trial Recruiting at 2 sites Observational Ages 18 and up Women only

Impact of altitude on headaches after cesarean delivery

Official title: Effect of Altitude on Postdural Puncture Headache After Caesarean Delivery: a Prospective, Multicentre Cohort Study

Run by B.P. Koirala Institute of Health Sciences · NCT05804448 · Data updated 2026-11-12

This study is testing how living at different altitudes affects the headaches that women experience after having a cesarean delivery with spinal anesthesia.

More Post-Dural Puncture Headache trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment292 (estimated)
SponsorB.P. Koirala Institute of Health Sciences
Academic / other
Locations2 sites (Jumla, Karnali and 1 other locations)
StatusRecruiting
StartedApril 18, 2023
Main results expectedDecember 20, 2026
Study endsDecember 20, 2026
Registry record updatedOctober 1, 2026
Trial IDNCT05804448 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parturients aged 18 and older, native to their resident altitude, and scheduled for cesarean delivery with spinal anesthesia.

Probably not a fit

Patients with hypertensive disorders, cerebrovascular diseases, or those requiring general anesthesia due to failed spinal anesthesia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate how altitude affects the incidence and severity of post-dural puncture headache (PDPH) in parturients undergoing spinal anesthesia for cesarean delivery. Conducted in Nepal, the study compares outcomes between high-altitude (Jumla) and low-altitude (Dharan) settings. Eligible participants will be screened based on specific criteria, and their baseline characteristics, including anxiety and chronic pain conditions, will be recorded. The diagnosis of PDPH will follow the international headache society's criteria.

Why it matters

Potential benefit: If successful, this study could provide insights into how altitude influences PDPH, potentially guiding better management strategies for parturients.

How similar studies have gone: While studies on PDPH exist, this specific investigation into altitude effects is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parturient, aged more than or equal to 18 years
* American society of Anesthesiologist 2 and 3
* Scheduled for elective and non-elective (category 2 \& 3) caesarean delivery with spinal anesthesia
* Native to their resident altitude i.e., those born, raised, and have continuously lived at the same altitude, at least for the past 1 year.

Exclusion Criteria:

* Hypertensive disorder
* Cerebrovascular disease
* Mental disorder (schizophrenia and other psychotic disorders)
* Known fetal anomalies
* Contraindication to spinal anaesthesia.
* Those requiring general anaesthesia for delivery due to failed spinal anesthesia
* Major post-delivery complications (severe haemorrhage, sepsis, or ICU admission)
* Those who migrate from their resident altitude (either low to high or vice versa) within 7 days post-delivery will also be excluded.

Where it's running

  • Karnali Academy of Health Sciences
    Jumla, Karnali, Nepal
    Recruiting
  • BP Koirala Institute of Health Sciences (BPKIHS)
    Dharān, Koshi, Nepal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.